App-Quantinova.ai

LOWER-DOSE SOLUMATRIX INDOMETHACIN: COMBINED SAFETY DATA FROM TWO PHASE 3 STUDIES IN PATIENTS WITH ACUTE PAIN FOLLOWING ELECTIVE SURGERY

R. Altman - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

Indomethacin

ANTIPHOSPHOLIPID SYNDROME AND MARCERS OF INFLAMATION

N. Seredavkina - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Interleukin

CHARATERIZATION OF MICRORNAS INVOLVED IN THE REGULATION OF ATHEROTRHOMBOSIS IN ANTIPHOSPHOLIPID SYNDROME AND SYSTEMIC LUPUS ERYTHEMATOSUS

C. Perez-Sanchez - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

CRITICAL ISSUES IN THE MANAGEMENT OF SLE

J. Calvo Alen - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Glucocorticoid

PREVENTION OF COLLATERAL DAMAGE BY IMMUNE INHIBITORY RECEPTORS

L. Meyaard - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

EFFECT OF RALOXIFENE ON OSTEOPOROSIS AND DISEASE ACTIVITY IN POSTMENOPAUSAL FEMALE WITH RHEUMATIC DISEASES

W. S. Lee - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Glucocorticoid

CLINICAL SIGNIFICANCE OF ANTI-ADALIMUMAB ANTIBODIES IN RHEUMATOID ARTHRITIS, ANKYLOSING SPONDILITIS AND PSORIASIC ARTHRITIS

A. Hoxha - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Adalimumab

EFFICIENCY OF PREVENTION VENOUS THROMBOEMBOLISM (VTE) IN PATIENTS WITH RHEUMATIC DISEASES AFTER TOTAL KNEE OR HIP ARTHROPLASTY

A. Rybnikov - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Pradax

THE RESULTS OF TOTAL HIP PROSTHESIS IN RHEUMATOID ARTHRITIS PATIENTS

S. Lapshina - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

Sulfasalazine

COMPARATIVE ANALYSIS OF THE FAULTS, COMPLICATIONS, FOLLOW UP IN PATIENTS WITH WIDE SPECTRUM FOR RHEUMATIC DISEASES ATTACHED TO TOTAL HIP REPLACEMENT

V. P. Pavlov - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

TWO-YEAR RETENTION AND EFFECTIVENESS OF IV ABATACEPT IN REAL-LIFE SETTING: RESULTS FROM THE ACTION STUDY

H. Nusslein - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Venous thrombosis

Tocilizumab

STUDY ON THE EFFICACY AND SAFETY OF TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN SLOVAKIA: ONE YEAR RESULTS OF PROSPECTIVE, OPEN LABEL STUDY CLOSE TO CLINICAL PRACTICE

I. Rybar - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Methotrexate

CLINICAL ANALYSIS OF PREOPERATIVE DEEP VEIN THROMBOSIS RISK FACTORS IN PATIENTS WITH TOTAL HIP ARTHROPLASTY

H. Wakabayashi - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

SAFETY AND TOLERABILITY OF MEDI-551 IN SUBJECTS WITH SYSTEMIC SCLEROSIS (SSC): RESULTS FROM A PHASE 1 RANDOMIZED, PLACEBO-CONTROLLED ESCALATING SINGLE-DOSE STUDY

E. Schiopu - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

MEDI 551

THE NUMBER OF MICRO-HEMORRHAGES AND MICRO-THROMBOSIS DETECTED BY NAILFOLD VIDEOCAPILLAROSCOPY IS PREDICTIVE OF DISEASE ACTIVITY IN PATIENTS WITH SYSTEMIC SCLEROSIS

D. Sambataro - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

N/A

THE RELATIONSHIP BETWEEN INFECTION AND ANTI-PHOSPHOLIPID SYNDROME: A SYSTEMIC REVIEW OF CASE REPORTS

N. Abdel-Wahab - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

INFLAMMATION IS STRONGLY ASSOCIATED WITH LUPUS ANTICOAGULANT POSITIVITY, INDEPENDENT OF KNOWN AUTOIMMUNE DISEASE AND RECENT VENOUS OR ARTERIAL THROMBOSIS

S. A. Just - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

FVIII

PREDICTIVE MARKERS OF PREECLAMPSIA DURING PREGNANCY IN PATIENTS WITH SYSTEMIC ERITHEMATOSUS LUPUS AND/OR ANTIPHOSPHOLIPID SYNDROME

E. Rodriguez-Almaraz - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Oraprine

PROGNOSTIC ROLE OF ALLELIC VARIATIONS OF GENES AFFECTING HAEMOSTASIS IN THE DEVELOPMENT OF ANTIPHOSPHOLIPID SYNDROME AND RENAL DAMAGE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

E. N. Borisov - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

VENOUS AND ARTERIAL THROMBOSIS IN SLE: DIFFERENCES IN NATURAL HISTORY

K. Hickman - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Prednisone

Filters

7277 Abstracts